Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELAS PHARMACIE 121 : revenue, balance sheet and financial ratios

SELAS PHARMACIE 121 is a French company founded 7 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75019), this company of category PME shows in 2021 a net income positive of 172 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS PHARMACIE 121 (SIREN 840184964)
Indicator 2021 2019
Revenue N/C N/C
Net income 172 211 € 89 279 €
EBITDA N/C N/C
Net margin N/C N/C

Revenue and income statement

In 2021, SELAS PHARMACIE 121 generates positive net income of 172 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2021: 89 k€ -> 172 k€.

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

172 211 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 549%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 13%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

548.962%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

13.262%

Solvency indicators evolution
SELAS PHARMACIE 121

Sector positioning

Debt ratio
548.96 2021
2019
2021
Q1: 29.04
Med: 85.54
Q3: 208.43
Average

In 2021, the debt ratio of SELAS PHARMACIE 121 (548.96) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
13.26% 2021
2019
2021
Q1: 25.89%
Med: 44.41%
Q3: 64.18%
Watch

In 2021, the financial autonomy of SELAS PHARMACIE 121 (13.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Positioning of SELAS PHARMACIE 121 in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2021, the value of SELAS PHARMACIE 121 is estimated at 1 975 331 € (range 1 270 148€ - 3 051 266€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2021
220 transactions
1270k€ 1975k€ 3051k€
1 975 331 € Range: 1 270 148€ - 3 051 266€
NAF 5 année 2021

Valuation method used

Net Income Multiple
172 211 € × 11.5x = 1 975 332 €
Range: 1 270 148€ - 3 051 267€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS PHARMACIE 121 with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS PHARMACIE 121

What is the revenue of SELAS PHARMACIE 121 ?

The revenue of SELAS PHARMACIE 121 is not publicly disclosed (confidential accounts filed with INPI).

Is SELAS PHARMACIE 121 profitable?

Yes, SELAS PHARMACIE 121 generated a net profit of 172 k€ in 2021.

Where is the headquarters of SELAS PHARMACIE 121 ?

The headquarters of SELAS PHARMACIE 121 is located in PARIS (75019), in the department Paris.

Where to find the tax return of SELAS PHARMACIE 121 ?

The tax return of SELAS PHARMACIE 121 is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS PHARMACIE 121 operate?

SELAS PHARMACIE 121 operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.